Zurich and Axa XL battle Giant Eagle over opioid defence costs
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
  • Free Trial
  • Log in

Zurich and Axa XL battle Giant Eagle over opioid defence costs

Bernard Goyder
January 15, 2020
  • X
  • LinkedIn
  • Show more sharing options
  • Print
  • X
  • LinkedIn
Narcotic drugs (opioids)

Zurich and Axa XL told a Pennsylvania federal judge they shouldn’t have to cover opioid-related defence costs for supermarket chain Giant Eagle because the retailer hasn’t yet exhausted its primary coverage.  

Carriers

Subscribers, log in here:

Fuel a smarter strategy with our actionable market intelligence

      • Gain a competitive edge and accelerate decision-making
      • Be empowered by insights that transform confusion to clarity
      • Uncover growth opportunities and prepare for potential threats
      • Fuel a smarter strategy for business growth
Request a free trial Already a subscriber? Log in now

Topics

News Axa XL Zurich Casualty/GL Regulation
BG
Bernard Goyder
Gift this article